| URN | urn:agi-llid:4609 |
|---|---|
| Connectivity | 1565 |
| Name | MYC |
| Description | v-myc myelocytomatosis viral oncogene homolog (avian) |
| Notes | The protein encoded by this gene is a multifunctional, nuclear phosphoprotein that plays a role in cell cycle progression, apoptosis and cellular transformation. It functions as a transcription factor that regulates transcription of specific target genes. Mutations, overexpression, rearrangement and translocation of this gene have been associated with a variety of hematopoietic tumors, leukemias and lymphomas, including Burkitt lymphoma. There is evidence to show that alternative translation initiations from an upstream, in-frame non-AUG (CUG) and a downstream AUG start site result in the production of two isoforms with distinct N-termini. The synthesis of non-AUG initiated protein is suppressed in Burkitt's lymphomas, suggesting its importance in the normal function of this gene. [provided by RefSeq] |
| Pathway | GHR -> ELK-SRF/MYC signaling |
|---|---|
| IL2R -> ELK-SRF/MYC signaling | |
| FibronectinR -> ICAP-1A/MYC signaling | |
| NCAM1 -> CREB/ELK-SRF/MYC signaling | |
| Sialophorin -> CTNNB/MYC/TP53 signaling | |
| NTRK -> AP-1/CREB/ELK-SRF/MYC/SMAD3/TP53 signaling | |
| GFR -> AP-1/CREB/CREBBP/ELK-SRF/MYC signaling | |
| IGF1R -> ELK-SRF/HIF1A/MYC/SREBF signaling | |
| Common Regulators | |
| PPARA Targets | |
| PPARG Targets | |
| RORG Targets | |
| LXRA Targets | |
| NR2C1 Targets | |
| ERA Pathway | |
| ERB Targets | |
| GR Targets | |
| PGR Targets | |
| LRH1 Targets | |
| SHP1 Targets |
| Ariadne Ontology | Oncogenes |
|---|---|
| Myc/Mad/Max |
| GO Molecular Function | transcription regulator activity |
|---|---|
| protein binding | |
| DNA binding | |
| sequence-specific DNA binding | |
| transcription factor activity | |
| double-stranded DNA binding | |
| protein heterodimerization activity |
| GO Cellular Component | cytoplasm |
|---|---|
| nucleus | |
| nucleolus | |
| nuclear body | |
| spindle |
| GO Biological Process | pigmentation |
|---|---|
| transcription initiation | |
| negative regulation of survival gene product expression | |
| positive regulation of cell proliferation | |
| induction of apoptosis by intracellular signals | |
| activation of pro-apoptotic gene products | |
| positive regulation of B cell apoptosis | |
| positive regulation of transcription from RNA polymerase II promoter | |
| regulation of mitotic cell cycle | |
| regulation of apoptosis | |
| activation of caspase activity | |
| regulation of telomere maintenance | |
| regulation of transcription | |
| regulation of transcription, DNA-dependent | |
| regulation of gene expression | |
| cellular iron ion homeostasis | |
| positive regulation of catalytic activity | |
| cell cycle arrest | |
| release of cytochrome c from mitochondria | |
| DNA fragmentation involved in apoptosis | |
| B cell apoptosis | |
| glucose metabolic process | |
| transcription | |
| transcription, DNA-dependent | |
| transcription from RNA polymerase II promoter | |
| middle ear morphogenesis | |
| skeletal system morphogenesis | |
| protein processing | |
| pathogenesis | |
| detection of mechanical stimulus involved in sensory perception of sound | |
| response to radiation | |
| response to alkaloid |
| Group | Oncogenes |
|---|---|
| Myc/Mad/Max | |
| cytoplasm | |
| nucleus | |
| nucleolus | |
| nuclear body | |
| spindle | |
| transcription regulator activity | |
| protein binding | |
| DNA binding | |
| sequence-specific DNA binding | |
| transcription factor activity | |
| double-stranded DNA binding | |
| protein heterodimerization activity | |
| pigmentation | |
| transcription initiation | |
| negative regulation of survival gene product expression | |
| positive regulation of cell proliferation | |
| induction of apoptosis by intracellular signals | |
| activation of pro-apoptotic gene products | |
| positive regulation of B cell apoptosis | |
| positive regulation of transcription from RNA polymerase II promoter | |
| regulation of mitotic cell cycle | |
| regulation of apoptosis | |
| activation of caspase activity | |
| regulation of telomere maintenance | |
| regulation of transcription | |
| regulation of transcription, DNA-dependent | |
| regulation of gene expression | |
| cellular iron ion homeostasis | |
| positive regulation of catalytic activity | |
| cell cycle arrest | |
| release of cytochrome c from mitochondria | |
| DNA fragmentation involved in apoptosis | |
| B cell apoptosis | |
| glucose metabolic process | |
| transcription | |
| transcription, DNA-dependent | |
| transcription from RNA polymerase II promoter | |
| middle ear morphogenesis | |
| skeletal system morphogenesis | |
| protein processing | |
| pathogenesis | |
| detection of mechanical stimulus involved in sensory perception of sound | |
| response to radiation | |
| response to alkaloid |
| Hugo ID | 7553 |
|---|
| Human chromosome position | 8q24.21 |
|---|
| LocusLink ID | 4609 |
|---|---|
| 17869 | |
| 24577 |
| Alias | MRTL |
|---|---|
| c-Myc | |
| bHLHe39 | |
| myc proto-oncogene protein | |
| avian myelocytomatosis viral oncogene homolog | |
| v-myc avian myelocytomatosis viral oncogene homolog | |
| myc-related translation/localization regulatory factor | |
| Myc2 | |
| Nird | |
| Niard | |
| AU016757 | |
| c-myc proto-oncogene | |
| mMyc | |
| RNCMYC | |
| MGC105490 | |
| myelocytomatosis viral oncogene homolog | |
| Avian myelocytomatosis viral (v-myc) oncogene homolog | |
| v-myc myelocytomatosis viral oncogene homolog (avian) | |
| cMyc | |
| 2900002K07Rik | |
| RIKEN cDNA 2900002K07 gene | |
| v-myc myelocytomatosis viral oncogene homolog | |
| myelocytomatosis oncogene | |
| Myc oncogene | |
| Myc transcription factor | |
| transcription factor Myc | |
| proto-oncogene Myc | |
| Myc locus | |
| C(MYC) | |
| MYC |
| Organism | Homo sapiens |
|---|---|
| Mus musculus | |
| Rattus norvegicus |
| OMIM ID | 190080 |
|---|---|
| 113970 |
| Swiss-Prot Accession | P01106 |
|---|---|
| Q14899 | |
| Q14901 | |
| Q16591 | |
| Q6LBK7 | |
| Q7KZ54 | |
| B2RSN1 | |
| P01108 | |
| O88594 | |
| Q6WDF1 | |
| Q8K3Z5 | |
| Q9Z197 | |
| P09416 | |
| Q6WDF7 |
| Unigene ID | Hs.202453 |
|---|---|
| Mm.2444 | |
| Rn.12072 |
| KEGG ID | mmu:17869 |
|---|---|
| rno:24577 |
| Swiss-Prot ID | MYC_HUMAN |
|---|---|
| MYC_MOUSE | |
| MYC_RAT | |
| Q14899_HUMAN | |
| B2RSN1_MOUSE |
| Cell Localization | Nucleus |
|---|
| GO ID | 0003690 |
|---|---|
| 0005515 | |
| 0043565 | |
| 0003700 | |
| 0001783 | |
| 0006309 | |
| 0006919 | |
| 0008633 | |
| 0007050 | |
| 0006879 | |
| 0050910 | |
| 0006006 | |
| 0008629 | |
| 0042474 | |
| 0008634 | |
| 0043473 | |
| 0043085 | |
| 0008284 | |
| 0045944 | |
| 0016485 | |
| 0042981 | |
| 0007346 | |
| 0032204 | |
| 0001836 | |
| 0043279 | |
| 0009314 | |
| 0048705 | |
| 0006352 | |
| 0005737 | |
| 0016604 | |
| 0005634 | |
| 0005819 | |
| 0003677 | |
| 0030528 | |
| 0002904 | |
| 0010468 | |
| 0045449 | |
| 0006355 | |
| 0006350 | |
| 0046982 | |
| 0009405 | |
| 0006366 | |
| 0006351 | |
| 0005730 |
| IPI ID | IPI00745564 |
|---|---|
| IPI00425663 | |
| IPI00033016 | |
| IPI00796046 | |
| IPI00131999 | |
| IPI00214655 |
| Mouse chromosome position | 15 32.0 cM |
|---|
| Homologene ID | 31092 |
|---|
| MGI ID | 97250 |
|---|
| Rat chromosome position | 7q33 |
|---|
| RGD ID | 3130 |
|---|